Table 2.
Response, n (%) | All treated patients N=55 |
---|---|
Overall CR/CRi | 39 (70·9)* |
CR | 31 (56·4) |
CRi | 8 (14·5) |
Blast-free hypoplastic or aplastic bone marrow | 4 (7·3) |
No response | 9 (16·4) |
Unknown or not evaluable† | 3 (5·5) |
95% CI, 57–82 (p<0·0001).
The three patients who were unknown or not evaluable died (days 8, 15, and 18) prior to the first disease assessment.
CR=complete remission; CRi=complete remission with incomplete hematologic recovery.